Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T13:41:45.953Z.
Consensus retrieved: 2026-10-06T10:18:13.138Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T13:41:45.953Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f12fe6f09ebba39ad61e3a87243b01e46bba3d7bd48a90cbad4cda1dbeff8bd9
Forward PE Ratio (N/A) = Dated Quote Price ($3.90) / Consensus Forward EPS ($-1.08)
FORWARD PE RATIO
N/A
Clene Inc.
Market Cap
$49.84M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Clene Inc. (CLNN) | $49.84M | N/A |
| biote Corp. (BTMD)vs › | $50.25M | N/A |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A |
| Celularity Inc. (CELU)vs › | $48.63M | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.04M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.30M | N/A |
| ImageneBio Inc (IMA)vs › | $52.67M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $3.90, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.08 | $-2.56 – $0.40 | 3 | n/m |
| 2027-12-31 | $-1.50 | $-1.79 – $-1.19 | 3 | n/m |
| 2028-12-31 | $2.29 | $-0.62 – $6.16 | 5 | 1.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
